Po-Ting Liu

Po-Ting Liu

Auto-generated profile, based on publicly available information

Po-Ting Liu

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
BJBoris Julg
Boris Julg
PLPo-Ting Liu
Po-Ting Liu
Kshitij WaghKshitij Wagh
Kshitij Wagh
WFWilliam M. Fischer
William M. Fischer
PAPeter Abbink
Peter Abbink
DBDan H. Barouch
Dan H. Barouch
A combination of HIV-1–specific broadly neutralizing antibodies is necessary to protect rhesus monkeys against a mixed SHIV challenge.

21 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJames B. Whitney
James B. Whitney
SLSo-Yon Lim
So-Yon Lim
COChrista E. Osuna
Christa E. Osuna
JKJessica L. Kublin
Jessica L. Kublin
ECElsa Chen
Elsa Chen
DBDan H. Barouch
Dan H. Barouch
The precise time when the viral reservoir is seeded during acute HIV-1 infection remains unclear. We previously demonstrated that the viral reservoir was seeded by day 3 following SIVmac251 infection in rhesus monkeys. Here we report the impact of initiating ART on day 0 (6 h), 1, 2, or 3 following intrarectal SIVmac251 infection in 20 rhesus monkeys (N = 5/group). After 6 months of daily suppressive ART, antiretroviral drugs were discontinued, and viral rebound was monitored. 0% (0 of 5), 20% (1 of 5), 60% (3 of 5), and 100% (5 of 5) of animals that initiated ART on days 0 (6 h), 1, 2, or 3, respectively, showed viral rebound following ART discontinuation and correlated with integrated viral DNA in lymph node CD4+ T cells. These data demonstrate that the viral reservoir is seeded within the first few days of infection and that early ART initiation limits the viral reservoir.

5 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAnthony M. Cadena
Anthony M. Cadena
JVJohn D. Ventura
John D. Ventura
PAPeter Abbink
Peter Abbink
EBErica N. Borducchi
Erica N. Borducchi
HTHubert Tuyishime
Hubert Tuyishime
DBDan H. Barouch
Dan H. Barouch
The establishment of a long-lived viral reservoir is the key obstacle for achieving an HIV-1 cure. However, the anatomic, virologic, and immunologic features of the viral reservoir in tissues during antiretroviral therapy (ART) remain poorly understood. Here we present a comprehensive necroscopic analysis of the SIV/SHIV viral reservoir in multiple lymphoid and non-lymphoid tissues from SIV/SHIV-infected rhesus macaques suppressed with ART for one year. Viral DNA is observed broadly in multiple tissues and is comparable in animals that had initiated ART at week 1 or week 52 of infection. In contrast, viral RNA is restricted primarily to lymph nodes. Ongoing viral RNA transcription is not the result of unsuppressed viral replication, as single-genome amplification and subsequent phylogenetic analysis do not show evidence of viral evolution. Gag-specific CD8+ T cell responses are predominantly observed in secondary lymphoid organs in animals chronically infected prior to ART and these responses are dominated by CD69+ populations. Overall, we observe that the viral reservoir in rhesus macaques is widely distributed across multiple tissue sites and that lymphoid tissues act as a site of persistent viral RNA transcription under conditions of long-term ART suppression.

27 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
PLPo-Ting Liu
Po-Ting Liu
BKBrandon F. Keele
Brandon F. Keele
PAPeter Abbink
Peter Abbink
NMNoe Bladimir Mercado
Noe Bladimir Mercado
JLJinyan Liu
Jinyan Liu
DBDan H. Barouch
Dan H. Barouch
Viral rebound following antiretroviral therapy (ART) discontinuation in HIV-1-infected individuals is believed to originate from a small pool of CD4+ T cells harboring replication-competent provirus. However, the origin and nature of the rebound virus has remained unclear. Recent studies have suggested that rebound virus does not originate directly from individual latent proviruses but rather from recombination events involving multiple proviruses. Here we evaluate the origin of rebound virus in 16 ART-suppressed, chronically SIV-infected rhesus monkeys following ART discontinuation. We sequence viral RNA and viral DNA in these animals prior to ART initiation, during ART suppression, and following viral rebound, and we compare rebound viral RNA after ART discontinuation with near full-length viral DNA from peripheral blood and lymph node mononuclear cells (PBMC and LNMC) during ART suppression. Sequences of initial rebound viruses closely match viral DNA sequences in PBMC and LNMC during ART suppression. Recombinant viruses are rare in the initial rebound virus populations but arise quickly within 2–4 weeks after viral rebound. These data suggest that intact proviral DNA in PBMC and LNMC during ART suppression is likely the direct origin of viral rebound in chronically SIV-infected rhesus monkeys following ART discontinuation.